FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH
|
|
- CAS-Nr.
- 116783-35-8
- Englisch Name:
- FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH
- Synonyma:
- Fmoc-Thr(Ac3GalNAcα)-OH;FMOC-Thr(GalNAc(Ac)3-α-D)-OH;GalNAc-Thr;GALNAC L-THREONINE;FMOC-L-THR(TNAC4)-OH;Fmoc-Thr(Ac3GalNAcα)-OH;Fmoc-Thr(AcAcNH-α-Gal)-OH;Fmoc-Thr(Ac3AcNH-α-Gal)-OH;FMoc-Thr-(Ac3AcNH-α-Gal)-OH;Fmoc-Thr(GalNAc(Ac)3-a-D)-OH
- CBNumber:
- CB0325578
- Summenformel:
- C33H38N2O13
- Molgewicht:
- 670.66
- MOL-Datei:
- 116783-35-8.mol
|
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH Eigenschaften
- Schmelzpunkt:
- 178-183°C
- Siedepunkt:
- 857.1±65.0 °C(Predicted)
- Dichte
- 1.38±0.1 g/cm3(Predicted)
- storage temp.
- -20°C
- Aggregatzustand
- Solid
- pka
- 3.32±0.10(Predicted)
- Farbe
- White to off-white
- Optische Aktivität
- [α]22/D +55.0°, c = 1% in chloroform
- InChIKey
- OXLCJWGAUPPZQJ-ZNHCDWFHSA-N
Sicherheit
WGK Germany |
3 |
|
|
HS Code |
2932 99 00 |
|
|
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White to off-white solid
Verwenden
Fluorescently labeled glycopeptides containing GalNAcα1-O-Ser/Thr residues provide valuable immunology probes for the development of cancer vaccines.
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 117)Lieferanten
- N-FMOC-O-(3,4,6,-TRI-O-ACETYL-2-ACETAMIDO-2-DEOXY-Α-D-GALACTOPYRANOSYL)-L-THREONINE
- Fmoc-L-Ser(α-D-GalNAc(Ac)3)-OH
- Fmoc-L-Thr(GalNAc(Ac)3-α-D)-OH
- Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-threonine≥ 97% (HPLC)
- Fmoc-Thr(AcAcNH-α-Gal)-OH Novabiochem
- N-FMOC-O-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-threonine
- Fmoc-L-Thr(α-D-GalNAc(Ac)3)-OH
- N-Fmoc-O-beta-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine
- Fmoc-L-Thr(TnAc4)-OH, N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine
- Fmoc-Thr(GalNAc(Ac)3-a-D)-OH
- FMOC-L-THR(TNAC4)-OH
- FMOC-L-THR(ALPHA-D-GALNAC(AC)3)-OH
- FMOC-THREONINE(GALNAC(AC)3-ALPHA-D)-OH
- FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH
- FMOC-THR(AC3ACNH-ALPHA-GAL)-OH
- GALNAC L-THREONINE
- Fmoc-L-Thr(TnAc4)-OH,N-alpha-(9-fluorenylmethyloxycarbonyl)-O-(2-acetamido-2deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyr
- N-alpha-(9-Fluoroenyloxycarbonyl)-o-(2-acetamido-2deoxy-3,4,6-tri-o-acetyl-alpha-d-galactopyranosyl)-l-threonine
- N-FMoc-O-[3,4,6-tri-O-acetyl-2-(acetylaMino)-2-deoxy-α-D-galactopyranosyl]-L-threonine
- N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-galactopyranosyl)-L-thereonine
- FMoc-Thr(2-acetaMido-3,4,6,-tri-O-acetyl-
2-deoxy-α-D-galactopyranosyl)-OH
- FMoc-Thr-(Ac3AcNH-α-Gal)-OH
- N-[(9H-Fluoren-9-ylMethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylaMino)-2-deoxy-α-D-galactopyranosyl]-L-threonine
- N-a-FMoc-O-b-(2-acetaMido-2-deoxy-3,4,6-tri-O-acetyl-a-D-galactopyranosyl)-L-threonine
- FMoc-Thr(α-D-GalNAc(Ac)3)-OH
- N-ALPHA-FMOC-O-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- N-ALPHA-FMOC-O-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-(2-ACETAMIDO-2DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE
- GalNAc-Thr
- N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine
- FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH USP/EP/BP
- Fmoc-Thr[GalNAc(Ac)3-α-D]-OH
- Fmoc-Thr(α-D-GalNAc(Ac)3)-OH
- ZINC77292789(Fmoc-Thr(galnac(Ac)3-alpha-D)-OH)
- L-Threonine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-
- Fmoc-L-Thr(α-D-GalNAc(Ac)3)-OH
- N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine
Fmoc-Thr(GalNAc(Ac)3-a-D)-OH
- 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-galactopyranosyl-Fmoc threonine
- L-Threonine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-
- Fmoc-Thr(α-D-Gal- NHAc(Ac)3)-OH
- Fmoc-Thr(AcAcNH-α-Gal)-OH
- N-(9H-fluoren-9-yl)methoxycarbonyl-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-α-D-galactopyranosyl)-L-threonine
- N-Fmoc-O-(2-acetamido-3,4,6-tri-O-acetyl-2-?deoxy-α-D-galactopyranosyl)-L-threonine
- Fmoc-Thr(Ac3GalNAcα)-OH
- FMOC-Thr(GalNAc(Ac)3-α-D)-OH
- inhibit,Inhibitor,ZINC77292789,ZINC-77292789
- Fmoc-L-Thr((Ac)3-α-D-GalNAc)-OH
- N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-L-threonine
- N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-((2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)-L-threonine
- Fmoc-Thr(Ac3GalNAcα)-OH
- Fmoc-Thr(Ac3AcNH-α-Gal)-OH
- N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-a-D-galactopyranosyl]-L-threonine
- (2S,3R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butanoic acid
- N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-Dgalactopyranosyl]-L-threonine
- Tn Antigen: Fmoc-Thr(GalNAc(Ac)3-α-D)-OH
- Fmoc-Thr(Ac3GalNAc-alpha-)-OH
- 116783-35-8